pathway,nums,percent,pvalue
Carbon metabolism,126,0.47619047619047616,0.0
Cytokine-cytokine receptor interaction,326,0.24539877300613497,0.0
DNA replication,35,1.4285714285714286,0.0
ECM-receptor interaction,89,0.4943820224719101,0.0
Fatty acid elongation,29,0.27586206896551724,0.0
Fatty acid metabolism,64,0.4375,0.0
Focal adhesion,204,0.6323529411764706,0.0
Huntington's disease,194,0.4484536082474227,0.0
Metabolic pathways,1315,0.3832699619771863,0.0
Mismatch repair,22,1.3636363636363635,0.0
Non-alcoholic fatty liver disease (NAFLD),151,0.44370860927152317,0.0
Nuclear pore complex,41,0.7317073170731707,0.0
Nucleotide excision repair,58,1.0,0.0
Parkinson's disease,144,0.2777777777777778,0.0
Protein digestion and absorption,110,0.33636363636363636,0.0
Pyrimidine metabolism,107,0.5420560747663551,0.0
Ribosome biogenesis in eukaryotes,125,0.392,0.0
RNA transport,167,0.6586826347305389,0.0
TGF-beta signaling pathway,112,0.5357142857142857,0.0
Nucleotide metabolism,84,0.5119047619047619,0.0
Biosynthesis of cofactors,152,0.3026315789473684,0.0
Nucleocytoplasmic transport,117,0.7008547008547008,0.0
Viral protein interaction with cytokine and cytokine receptor,95,0.24210526315789474,0.0
"Parathyroid hormone synthesis, secretion and action",108,0.35185185185185186,0.0
Thermogenesis,231,0.4805194805194805,0.0
Choline metabolism in cancer,98,0.2755102040816326,0.0
Amoebiasis,107,0.42990654205607476,0.0
Parkinson disease,264,0.35984848484848486,0.0
Amyotrophic lateral sclerosis,369,0.5257452574525745,0.0
Huntington disease,302,0.4271523178807947,0.0
Non-alcoholic fatty liver disease,156,0.47435897435897434,0.0
Antigen processing and presentation,97,0.3917525773195876,0.001
Base excision repair,49,0.673469387755102,0.001
Ether lipid metabolism,48,0.08333333333333333,0.001
Propanoate metabolism,34,0.47058823529411764,0.001
Influenza A,173,0.5491329479768786,0.001
Homologous recombination,42,0.38095238095238093,0.002
Phospholipase D signaling pathway,150,0.36,0.002
Alzheimer's disease,175,0.41714285714285715,0.003
Cell cycle,157,0.7133757961783439,0.003
Ferroptosis,42,0.40476190476190477,0.003
Protein processing in endoplasmic reticulum,183,0.14207650273224043,0.003
Ras signaling pathway,242,0.3347107438016529,0.003
Alzheimer disease,383,0.391644908616188,0.003
Alcoholism,205,0.17073170731707318,0.003
Circadian rhythm,37,0.21621621621621623,0.004
Oxidative phosphorylation,151,0.2913907284768212,0.004
Purine metabolism,185,0.40540540540540543,0.004
Motor proteins,196,0.5204081632653061,0.004
Pathways in cancer,543,0.49171270718232046,0.004
Prion disease,267,0.5131086142322098,0.004
GINS complex,4,2.0,0.005
Cholesterol metabolism,50,0.06,0.005
beta-Alanine metabolism,37,0.2972972972972973,0.006
Human T-cell leukemia virus 1 infection,249,0.5943775100401606,0.006
"Valine, leucine and isoleucine degradation",57,0.47368421052631576,0.007
Spliceosome,186,0.5645161290322581,0.008
Hippo signaling pathway,158,0.2974683544303797,0.009
Arachidonic acid metabolism,95,0.08421052631578947,0.01
Bacterial invasion of epithelial cells,76,0.39473684210526316,0.01
Primary immunodeficiency,36,0.3333333333333333,0.01
Arrhythmogenic right ventricular cardiomyopathy,77,0.16883116883116883,0.01
Drug metabolism - other enzymes,92,0.33695652173913043,0.012
"Fatty acid biosynthesis, elongation, endoplasmic reticulum",13,0.23076923076923078,0.012
Neutrophil extracellular trap formation,208,0.30288461538461536,0.012
Proteoglycans in cancer,205,0.5560975609756098,0.012
Endocytosis,297,0.43434343434343436,0.013
Retrograde endocannabinoid signaling,150,0.19333333333333333,0.013
SNARE interactions in vesicular transport,33,0.15151515151515152,0.013
Butanoate metabolism,28,0.21428571428571427,0.014
Nicotinate and nicotinamide metabolism,45,0.13333333333333333,0.015
"Lysine degradation, lysine => saccharopine => acetoacetyl-CoA",11,0.45454545454545453,0.016
Wnt signaling pathway,180,0.18888888888888888,0.018
Hypertrophic cardiomyopathy,91,0.4175824175824176,0.018
Hippo signaling pathway -multiple species,26,0.2692307692307692,0.02
p53 signaling pathway,74,0.581081081081081,0.02
Ribosome,187,0.24064171122994651,0.02
Breast cancer,147,0.2585034013605442,0.02
2-Oxocarboxylic acid metabolism,34,0.14705882352941177,0.021
"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate",27,0.14814814814814814,0.022
Hippo signaling pathway - multiple species,27,0.25925925925925924,0.022
Cytochrome bc1 complex,10,0.3,0.023
Salivary secretion,88,0.11363636363636363,0.023
"Spliceosome, 35S U5-snRNP",36,0.6111111111111112,0.023
Graft-versus-host disease,62,0.3387096774193548,0.023
Viral carcinogenesis,228,0.5526315789473685,0.024
PI3K-Akt signaling pathway,373,0.46380697050938335,0.025
Salmonella infection,253,0.5296442687747036,0.026
Malaria,57,0.49122807017543857,0.026
Human papillomavirus infection,361,0.4709141274238227,0.027
Fat digestion and absorption,43,0.06976744186046512,0.031
Arrhythmogenic right ventricular cardiomyopathy (ARVC),72,0.16666666666666666,0.033
Chemical carcinogenesis - reactive oxygen species,223,0.452914798206278,0.034
Chronic myeloid leukemia,76,0.42105263157894735,0.035
ABC transporters,52,0.11538461538461539,0.037
Steroid biosynthesis,20,0.15,0.037
Leukocyte transendothelial migration,121,0.5289256198347108,0.038
Oocyte meiosis,123,0.37398373983739835,0.039
Dilated cardiomyopathy,94,0.30851063829787234,0.039
BRCA1-associated genome surveillance complex (BASC),16,0.6875,0.04
"Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate",10,0.3,0.04
Glyoxylate and dicarboxylate metabolism,32,0.09375,0.041
"Citrate cycle (TCA cycle, Krebs cycle)",24,0.125,0.043
Necroptosis,175,0.4057142857142857,0.043
Melanoma,72,0.3194444444444444,0.044
Intestinal immune network for IgA production,45,0.4,0.045
Fatty acid degradation,53,0.37735849056603776,0.046
Activin signaling,10,0.3,0.047
Human immunodeficiency virus 1 infection,239,0.5313807531380753,0.05
Biosynthesis of unsaturated fatty acids,36,0.2777777777777778,0.051
Complement and coagulation cascades,94,0.19148936170212766,0.051
ATP-dependent chromatin remodeling,136,0.38235294117647056,0.051
Tyrosine metabolism,41,0.07317073170731707,0.053
"Spliceosome, U4/U6.U5 tri-snRNP",32,0.4375,0.054
Relaxin signaling pathway,129,0.3798449612403101,0.054
RF-C complex,5,1.2,0.055
JAK-STAT signaling pathway,171,0.2982456140350877,0.055
Glutamatergic synapse,116,0.07758620689655173,0.056
"Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA",4,0.75,0.056
Metabolism of xenobiotics by cytochrome P450,75,0.17333333333333334,0.058
Alcoholic liver disease,141,0.3971631205673759,0.062
Hippo signaling,15,0.2,0.064
Lysine degradation,67,0.2537313432835821,0.064
Primary bile acid biosynthesis,18,0.16666666666666666,0.064
GnRH signaling pathway,90,0.35555555555555557,0.065
Progesterone-mediated oocyte maturation,92,0.4673913043478261,0.07
Glucagon signaling pathway,108,0.3055555555555556,0.072
Starch and sucrose metabolism,36,0.08333333333333333,0.075
RNA degradation,90,0.24444444444444444,0.076
Efferocytosis,155,0.2903225806451613,0.076
Pancreatic secretion,116,0.14655172413793102,0.078
Jak-STAT signaling pathway,159,0.29559748427672955,0.079
Peroxisome,87,0.3448275862068966,0.08
"Spliceosome, U2-snRNP",21,0.7619047619047619,0.085
Tryptophan metabolism,54,0.2037037037037037,0.086
Herpes simplex virus 1 infection,458,0.24672489082969432,0.086
Synaptic vesicle cycle,77,0.16883116883116883,0.087
Rheumatoid arthritis,87,0.5977011494252874,0.087
AMPK signaling pathway,128,0.2890625,0.089
Epstein-Barr virus infection,230,0.5695652173913044,0.093
Carbohydrate digestion and absorption,49,0.12244897959183673,0.094
"Ribosome, eukaryotes",98,0.2857142857142857,0.094
Basal transcription factors,45,0.24444444444444444,0.096
AGE-RAGE signaling pathway in diabetic complications,101,0.6633663366336634,0.097
Long-term depression,61,0.26229508196721313,0.098
Cardiac muscle contraction,87,0.42528735632183906,0.1
Yersinia infection,135,0.562962962962963,0.105
"Growth hormone synthesis, secretion and action",117,0.27350427350427353,0.109
Thyroid hormone synthesis,74,0.2702702702702703,0.11
Allograft rejection,62,0.3225806451612903,0.111
Th1 and Th2 cell differentiation,89,0.4606741573033708,0.113
IL-17 signaling pathway,93,0.24731182795698925,0.114
"Fatty acid biosynthesis, elongation, mitochondria",6,0.5,0.115
Adherens junction,93,0.5053763440860215,0.118
beta-Oxidation,13,0.23076923076923078,0.124
JAK-STAT signaling,19,0.42105263157894735,0.125
Diabetic cardiomyopathy,211,0.5781990521327014,0.126
Hypertrophic cardiomyopathy (HCM),84,0.44047619047619047,0.128
"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",6,0.5,0.129
Signaling pathways regulating pluripotency of stem cells,141,0.3262411347517731,0.131
African trypanosomiasis,39,0.28205128205128205,0.132
Inositol phosphate metabolism,73,0.2054794520547945,0.133
HTLV-I infection,283,0.5759717314487632,0.137
RPA complex,3,1.3333333333333333,0.147
Glycerolipid metabolism,64,0.234375,0.15
Cell adhesion molecules (CAMs),169,0.3136094674556213,0.159
Pathways of neurodegeneration - multiple diseases,471,0.42250530785562634,0.16
Cell cycle - G1/S transition,13,0.38461538461538464,0.162
Chemokine signaling pathway,204,0.39705882352941174,0.164
Tight junction,179,0.5251396648044693,0.168
Viral life cycle - HIV-1,61,0.47540983606557374,0.168
Cell adhesion molecules,182,0.2857142857142857,0.17
Natural killer cell mediated cytotoxicity,123,0.43089430894308944,0.172
Fanconi anemia pathway,51,0.09803921568627451,0.173
Prolactin signaling pathway,74,0.32432432432432434,0.173
"V-type ATPase, eukaryotes",24,0.375,0.173
Pancreatic cancer,76,0.47368421052631576,0.173
Fc gamma R-mediated phagocytosis,97,0.5360824742268041,0.176
Pentose phosphate pathway,34,0.11764705882352941,0.177
Chemical carcinogenesis - DNA adducts,84,0.13095238095238096,0.177
Mucin type O-glycan biosynthesis,32,0.09375,0.18
Immunoproteasome,18,0.7222222222222222,0.181
ErbB signaling pathway,86,0.20930232558139536,0.186
Estrogen signaling pathway,134,0.27611940298507465,0.186
Hepatitis C,166,0.42168674698795183,0.19
Apoptosis,137,0.5547445255474452,0.191
Triacylglycerol biosynthesis,16,0.375,0.193
Ovarian steroidogenesis,65,0.046153846153846156,0.207
"Spliceosome, Prp19/CDC5L complex",13,0.23076923076923078,0.207
Polycomb repressive complex,84,0.36904761904761907,0.207
Glycerophospholipid metabolism,99,0.1919191919191919,0.209
Prion diseases,34,0.3235294117647059,0.213
Folate biosynthesis,26,0.2692307692307692,0.214
Autoimmune thyroid disease,78,0.23076923076923078,0.214
Chemical carcinogenesis - receptor activation,225,0.38222222222222224,0.216
Dopaminergic synapse,138,0.2028985507246377,0.23
Notch signaling pathway,63,0.25396825396825395,0.23
Neurotrophin signaling pathway,121,0.35537190082644626,0.231
"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA",6,0.5,0.232
Proteasome,47,0.425531914893617,0.233
Platinum drug resistance,80,0.35,0.24
Central carbon metabolism in cancer,69,0.2753623188405797,0.248
Adipocytokine signaling pathway,73,0.3972602739726027,0.253
Hepatocellular carcinoma,174,0.4482758620689655,0.26
Drug metabolism - cytochrome P450,72,0.1111111111111111,0.261
Hepatitis B,163,0.5950920245398773,0.261
Caffeine metabolism,6,0.5,0.262
Staphylococcus aureus infection,128,0.1015625,0.265
B cell receptor signaling pathway,85,0.43529411764705883,0.274
Transcriptional misregulation in cancer,224,0.21428571428571427,0.276
Gastric cancer,150,0.22,0.276
FoxO signaling pathway,133,0.44360902255639095,0.28
MicroRNAs in cancer,303,0.30363036303630364,0.293
Cysteine and methionine metabolism,57,0.10526315789473684,0.294
Sphingolipid metabolism,57,0.15789473684210525,0.295
Biosynthesis of amino acids,84,0.2976190476190476,0.296
Exon junction complex (EJC),22,0.45454545454545453,0.298
Glioma,74,0.2972972972972973,0.302
Apoptosis - multiple species,33,0.2727272727272727,0.303
One carbon pool by folate,19,0.3684210526315789,0.306
Collecting duct acid secretion,27,0.1111111111111111,0.32
Axon guidance,183,0.3770491803278688,0.327
Coronavirus disease - COVID-19,249,0.5220883534136547,0.327
Adrenergic signaling in cardiomyocytes,156,0.4166666666666667,0.338
H/ACA ribonucleoprotein complex,4,1.0,0.343
Sm core complex,8,0.625,0.35
Sulfur metabolism,14,0.21428571428571427,0.351
Origin recognition complex,6,0.5,0.356
Systemic lupus erythematosus,149,0.12080536912751678,0.358
Biosynthesis of nucleotide sugars,38,0.5,0.361
Mitophagy - animal,68,0.058823529411764705,0.372
Longevity regulating pathway,90,0.2222222222222222,0.389
Regulation of actin cytoskeleton,239,0.5104602510460251,0.389
Fructose and mannose metabolism,38,0.21052631578947367,0.39
Type I diabetes mellitus,69,0.2753623188405797,0.4
Cul3-SPOP complex,5,0.6,0.404
Longevity regulating pathway - multiple species,62,0.3709677419354839,0.41
Renal cell carcinoma,68,0.3235294117647059,0.414
Hematopoietic cell lineage,98,0.30612244897959184,0.419
TGF-beta signaling,8,0.375,0.422
Thyroid hormone signaling pathway,120,0.5083333333333333,0.432
Gastric acid secretion,75,0.14666666666666667,0.44
Legionellosis,60,0.18333333333333332,0.443
Viral myocarditis,87,0.47126436781609193,0.473
NF-kappa B signaling pathway,114,0.3684210526315789,0.475
cAMP signaling pathway,224,0.23660714285714285,0.481
Herpes simplex infection,215,0.42790697674418604,0.488
Endometrial cancer,58,0.05172413793103448,0.491
EGFR tyrosine kinase inhibitor resistance,79,0.20253164556962025,0.494
Insulin secretion,86,0.11627906976744186,0.495
RNA polymerase,36,0.4444444444444444,0.499
"Proteasome, 20S core particle",15,0.2,0.501
HIF-1 signaling pathway,120,0.35,0.506
MAPK (ERK1/2) signaling,8,0.375,0.514
Oxytocin signaling pathway,154,0.33766233766233766,0.515
Inflammatory mediator regulation of TRP channels,127,0.18110236220472442,0.517
"RNA polymerase III, eukaryotes",18,0.2777777777777778,0.519
GnRH secretion,63,0.12698412698412698,0.532
Fc epsilon RI signaling pathway,68,0.3088235294117647,0.538
mmuK signaling pathway,301,0.43853820598006643,0.539
"Gluconeogenesis, oxaloacetate => fructose-6P",19,0.15789473684210525,0.552
Renin secretion,76,0.11842105263157894,0.552
"Spliceosome, U1-snRNP",11,0.2727272727272727,0.554
T cell receptor signaling pathway,125,0.392,0.557
"Adenine ribonucleotide biosynthesis, IMP => ADP,ATP",20,0.25,0.56
Glutathione metabolism,74,0.17567567567567569,0.568
MAPK signaling pathway,252,0.4087301587301587,0.569
Cellular senescence,183,0.5519125683060109,0.571
Lysosome,136,0.36764705882352944,0.575
TREX complex,10,0.3,0.58
Chagas disease,103,0.33980582524271846,0.581
Acute myeloid leukemia,70,0.2,0.587
Cytosolic DNA-sensing pathway,80,0.375,0.588
Endocrine and other factor-regulated calcium reabsorption,61,0.18032786885245902,0.596
Ubiquitin mediated proteolysis,151,0.33112582781456956,0.603
Toll-like receptor signaling pathway,104,0.41346153846153844,0.604
Sphingolipid signaling pathway,127,0.41732283464566927,0.614
Long-term potentiation,67,0.1791044776119403,0.635
NOD-like receptor signaling pathway,220,0.4590909090909091,0.635
Osteoclast differentiation,140,0.5,0.641
"RNA polymerase I, eukaryotes",13,0.23076923076923078,0.642
Fluid shear stress and atherosclerosis,147,0.46938775510204084,0.646
Insulin resistance,110,0.5,0.653
Inflammatory bowel disease (IBD),59,0.6440677966101694,0.654
Autophagy - animal,167,0.25149700598802394,0.658
Amino sugar and nucleotide sugar metabolism,52,0.40384615384615385,0.664
Glycolysis / Gluconeogenesis,70,0.18571428571428572,0.664
"Aminoacyl-tRNA biosynthesis, eukaryotes",38,0.2631578947368421,0.671
Cortisol synthesis and secretion,72,0.041666666666666664,0.671
Tuberculosis,180,0.45,0.673
TNF signaling pathway,115,0.4782608695652174,0.681
Type II diabetes mellitus,48,0.14583333333333334,0.683
Endocrine resistance,93,0.3655913978494624,0.686
Chagas disease (American trypanosomiasis),101,0.3564356435643564,0.691
Cushing syndrome,162,0.3148148148148148,0.693
mRNA surveillance pathway,105,0.19047619047619047,0.698
Wnt signaling,38,0.07894736842105263,0.707
"Alanine, aspartate and glutamate metabolism",41,0.3902439024390244,0.722
Human cytomegalovirus infection,255,0.5529411764705883,0.725
RIG-I-like receptor signaling pathway,73,0.3972602739726027,0.733
PPAR signaling pathway,90,0.23333333333333334,0.748
C-type lectin receptor signaling pathway,112,0.4732142857142857,0.748
Thyroid cancer,37,0.08108108108108109,0.749
Non-small cell lung cancer,72,0.4861111111111111,0.755
Citrate cycle (TCA cycle),32,0.21875,0.764
Leishmaniasis,70,0.6428571428571429,0.775
Calcium signaling pathway,254,0.2874015748031496,0.777
Phagosome,192,0.4583333333333333,0.779
PD-L1 expression and PD-1 checkpoint pathway in cancer,88,0.4431818181818182,0.784
cGMP-PKG signaling pathway,175,0.37142857142857144,0.794
Galactose metabolism,34,0.23529411764705882,0.795
Pertussis,77,0.36363636363636365,0.797
Amyotrophic lateral sclerosis (ALS),52,0.23076923076923078,0.798
Prostate cancer,99,0.32323232323232326,0.811
Lipid and atherosclerosis,216,0.375,0.816
Serotonergic synapse,133,0.08270676691729323,0.821
MAPK (JNK) signaling,21,0.2857142857142857,0.825
mTOR signaling pathway,158,0.22784810126582278,0.826
Rap1 signaling pathway,218,0.42201834862385323,0.828
Amphetamine addiction,69,0.21739130434782608,0.833
MAPK (p38) signaling,22,0.2727272727272727,0.834
Melanogenesis,100,0.08,0.836
Small cell lung cancer,93,0.6129032258064516,0.841
Toxoplasmosis,109,0.6880733944954128,0.841
Neuroactive ligand-receptor interaction,393,0.05597964376590331,0.842
Bladder cancer,41,0.2926829268292683,0.846
Aldosterone synthesis and secretion,105,0.13333333333333333,0.868
Th17 cell differentiation,107,0.5700934579439252,0.881
Inflammatory bowel disease,62,0.5645161290322581,0.882
Hedgehog signaling pathway,58,0.15517241379310345,0.884
Arginine and proline metabolism,57,0.22807017543859648,0.885
Circadian entrainment,100,0.05,0.897
Cholinergic synapse,114,0.24561403508771928,0.9
Apelin signaling pathway,145,0.3724137931034483,0.902
Colorectal cancer,88,0.32954545454545453,0.917
Retinol metabolism,97,0.030927835051546393,0.92
Aldosterone-regulated sodium reabsorption,39,0.28205128205128205,0.932
Asthma,25,0.12,0.94
Phosphatidylinositol signaling system,99,0.2222222222222222,0.942
Arginine biosynthesis,20,0.2,0.945
Cul4-DDB1-CSA complex,6,0.5,0.948
Aminoacyl-tRNA biosynthesis,84,0.08333333333333333,0.951
Cul4-DDB1-DDB2 complex,6,0.5,0.952
Vascular smooth muscle contraction,145,0.36551724137931035,0.953
Kaposi sarcoma-associated herpesvirus infection,223,0.4798206278026906,0.957
Mineral absorption,56,0.10714285714285714,0.958
Basal cell carcinoma,63,0.06349206349206349,0.961
Spinocerebellar ataxia,141,0.2695035460992908,0.964
Gap junction,86,0.16279069767441862,0.965
VEGF signaling pathway,58,0.43103448275862066,0.965
Insulin signaling pathway,143,0.34965034965034963,0.977
Lsm 2-8 complex,7,0.42857142857142855,0.989
Platelet activation,126,0.5555555555555556,0.992
Dorso-ventral axis formation,26,0.11538461538461539,0.993
Lsm 1-7 complex,7,0.42857142857142855,0.994
Measles,145,0.4827586206896552,1.0
